Header cover image

Taiwanese (TAIEX) Biotech Industry Analysis

UpdatedMay 23, 2025
DataAggregated Company Financials
Companies67
  • 7D-1.0%
  • 3M-15.9%
  • 1Y-6.4%
  • YTDn/a

In the last week, the Biotech industry is up 1.8%, with Lin BioScience up 17%. In contrast, the industry has lost 7.2% in the last 12 months. Looking forward, earnings are forecast to grow by 53% annually.

Industry Valuation and Performance

Has the Taiwanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 23 May 2025NT$490.2bNT$30.0b-NT$6,443,317,000.0031.3x-76.1x16.3x
Sun, 20 Apr 2025NT$470.0bNT$28.3b-NT$7,180,905,000.0031x-65.4x16.6x
Tue, 18 Mar 2025NT$531.4bNT$28.1b-NT$8,214,097,000.0032.9x-64.7x18.9x
Thu, 13 Feb 2025NT$598.1bNT$24.8b-NT$10,902,841,000.0038.1x-54.9x24.1x
Sat, 11 Jan 2025NT$562.3bNT$24.8b-NT$10,902,841,000.0034.9x-51.6x22.7x
Mon, 09 Dec 2024NT$514.8bNT$24.8b-NT$10,848,531,000.0037.2x-47.5x20.8x
Wed, 06 Nov 2024NT$548.6bNT$23.5b-NT$10,829,095,000.0042.5x-50.7x23.4x
Fri, 04 Oct 2024NT$551.8bNT$23.5b-NT$10,829,095,000.0036x-51x23.5x
Sun, 01 Sep 2024NT$583.8bNT$23.5b-NT$10,883,302,000.0035.1x-53.6x24.9x
Tue, 30 Jul 2024NT$549.0bNT$21.9b-NT$11,053,865,000.0042.1x-49.7x25x
Thu, 27 Jun 2024NT$520.7bNT$21.9b-NT$11,110,643,000.0043.2x-46.9x23.7x
Sat, 25 May 2024NT$489.1bNT$21.9b-NT$11,084,581,000.0042x-44.1x22.3x
Mon, 22 Apr 2024NT$429.2bNT$21.1b-NT$12,242,614,000.0046.6x-35.1x20.3x
Wed, 20 Mar 2024NT$433.4bNT$21.0b-NT$10,159,738,000.0044.5x-42.7x20.6x
Fri, 16 Feb 2024NT$438.6bNT$19.9b-NT$9,857,794,000.0040.4x-44.5x22x
Sun, 14 Jan 2024NT$458.8bNT$19.8b-NT$9,748,146,000.0038.9x-47.1x23.2x
Tue, 12 Dec 2023NT$472.7bNT$19.9b-NT$9,737,975,000.0043x-48.5x23.8x
Thu, 09 Nov 2023NT$486.4bNT$18.5b-NT$10,820,022,000.0050.3x-45x26.2x
Sat, 07 Oct 2023NT$472.2bNT$18.3b-NT$10,774,226,000.0045.1x-43.8x25.8x
Mon, 04 Sep 2023NT$493.2bNT$18.3b-NT$10,596,353,000.0043.3x-46.5x26.9x
Wed, 02 Aug 2023NT$475.6bNT$18.6b-NT$10,793,316,000.0051.4x-44.1x25.6x
Fri, 30 Jun 2023NT$493.3bNT$18.7b-NT$10,709,428,000.0044.4x-46.1x26.4x
Sun, 28 May 2023NT$490.6bNT$19.0b-NT$9,947,560,000.0044.2x-49.3x25.9x
Tue, 25 Apr 2023NT$516.4bNT$18.4b-NT$9,803,110,000.0040.8x-52.7x28x
Thu, 23 Mar 2023NT$494.6bNT$22.5b-NT$7,261,002,000.0037.1x-68.1x22x
Sat, 18 Feb 2023NT$521.9bNT$21.8b-NT$7,832,470,000.0038x-66.6x23.9x
Mon, 16 Jan 2023NT$487.4bNT$21.8b-NT$7,778,690,000.0035.9x-62.7x22.4x
Wed, 14 Dec 2022NT$518.7bNT$21.8b-NT$7,522,211,000.0037.6x-69x23.8x
Fri, 11 Nov 2022NT$479.5bNT$23.1b-NT$6,619,282,000.0036.2x-72.4x20.8x
Sun, 09 Oct 2022NT$511.1bNT$23.1b-NT$6,633,590,000.0038.2x-77.1x22.1x
Tue, 06 Sep 2022NT$655.8bNT$23.0b-NT$6,502,954,000.0045.3x-100.8x28.5x
Thu, 04 Aug 2022NT$537.7bNT$22.5b-NT$5,642,821,000.0031.8x-95.3x23.9x
Sat, 02 Jul 2022NT$530.6bNT$22.5b-NT$5,642,821,000.0030.6x-94x23.5x
Mon, 30 May 2022NT$498.2bNT$22.5b-NT$5,642,821,000.0031.8x-88.3x22.1x
Price to Earnings Ratio

-88.3x


Total Market Cap: NT$498.2bTotal Earnings: -NT$5,642,821,000.00Total Revenue: NT$22.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Biotech Industry Price to Earnings3Y Average -57.7x202320242025
Current Industry PE
  • Investors are pessimistic on the Taiwanese Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 23.2x is higher than the industry's current PS ratio of 16.5x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 10% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Taiwanese Biotech compare with similar industries?

TW Market-0.24%
Healthcare1.89%
Biotech-1.00%
Biotech-1.00%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4726 Mycenax BiotechNT$37.9013.6%
+NT$941.9m
-10.4%PS10.8x
6617 Gongwin Biopharm HoldingsNT$114.006.5%
+NT$882.4m
-39.4%PS419.9x
6541 Tanvex BioPharmaNT$55.704.1%
+NT$524.7m
46.2%PS163.6x
6810 Bio Preventive MedicineNT$31.9038.7%
+NT$440.1m
-16.3%n/a
6712 Ever Supreme Bio TechnologyNT$170.503.6%
+NT$430.3m
-4.8%PE31.3x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

4726

NT$37.90

Mycenax Biotech

7D

13.6%

1Y

-10.4%

6550

NT$42.10

Polaris Group

7D

-3.3%

1Y

-38.3%

4728

NT$408.00

Sunmax Biotechnology

7D

-7.0%

1Y

59.1%

6617

NT$114.00

Gongwin Biopharm Holdings

7D

6.5%

1Y

-39.4%

6712

NT$170.50

Ever Supreme Bio Technology

7D

3.6%

1Y

-4.8%

4174

NT$35.80

OBI Pharma

7D

-4.0%

1Y

-39.3%

6949

NT$127.00

Pell Bio-Med Technology

7D

-2.3%

1Y

-11.5%

6657

NT$75.60

Energenesis BiomedicalLTD

7D

4.9%

1Y

39.2%

6541

NT$55.70

Tanvex BioPharma

7D

4.1%

1Y

46.2%

6446

NT$488.00

PharmaEssentia

7D

-3.2%

1Y

17.0%

4117

NT$20.90

General Biologicals

7D

34.8%

1Y

0.5%

7808

NT$41.90

BIONET Therapeutics

7D

-8.9%

1Y

n/a

6810

NT$31.90

Bio Preventive Medicine

7D

38.7%

1Y

-16.3%

6976

NT$18.20

Acepodia

7D

-3.7%

1Y

-34.8%

6696

NT$142.50

Lin BioScience

7D

2.2%

1Y

57.3%